Degrees Of Change: Regulatory Rollbacks. May 22, 2020, Part 1
Science Friday
Science Friday and WNYC Studios
4.4 • 6.3K Ratings
🗓️ 22 May 2020
⏱️ 46 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | This is Science Friday. I'm Ira Plato. Just a quick note before we get started, as we have switched |
| 0:06.2 | to recording our show, we miss you. Yeah, you. We miss talking to you, and we want you to say hello. |
| 0:14.4 | Talk to us on Science Friday Voxpop app on Twitter, or you can even email us, SciFri at Science Friday.com. |
| 0:22.7 | And now, all over the country, states that shut down to slow coronavirus transmission are now |
| 0:28.8 | reopening. And in many states, the number of cases of COVID-19 continues to rise. |
| 0:35.6 | But for everyone holding their breath for a coronavirus vaccine, one company |
| 0:40.2 | working on a candidate reported good news this week. Antibodies. Yes, a small number of |
| 0:46.2 | human participants in a phase one clinical trial produced antibodies when injected with the vaccine. |
| 0:53.7 | Here to tell us the latest in the quest for a COVID vaccine and other short subjects in science |
| 0:59.5 | is Amerifan, reporter for Vox, based in Washington, D.C. Welcome back. |
| 1:05.3 | Thanks for having me. |
| 1:06.2 | Okay, can we start with this vaccine candidate? |
| 1:09.2 | Exactly what can we celebrate and may it be too soon to |
| 1:13.5 | celebrate? It may be a little too soon to celebrate, but it is still good news. This is from a |
| 1:19.3 | company called Moderna. And what they've developed is a vaccine that uses MRI. In this case, |
| 1:25.4 | it uses a small chunk of genetic material, and that uses |
| 1:28.9 | the cell's internal machinery to produce a fragment of the virus, and then the immune system |
| 1:34.0 | can then use that for target practice as a sort of a warm-up to dealing with the real virus |
| 1:39.2 | if it does ever infect. And this company reported this week that in a clinical trial that it has underway, they |
| 1:46.0 | reported that eight patients who were treated with this vaccine generated antibodies at the same |
| 1:52.0 | level as people who were naturally infected and recovered from the virus. So it showed that they |
| 1:57.1 | could generate a pretty strong response with this vaccine. Now let's talk about the not so good news, which maybe it's not quite ready for prime time yet. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Science Friday and WNYC Studios, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Science Friday and WNYC Studios and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

